EFdA (islatravir) is a nucleoside analog that is being developed by Merck for implant-based HIV treatment.
Found 2 search result(s) for EFdA OR islatravir.
3.4 Raymond Schinazi — Discovery and Development of Novel NRTIs
(HIV/AIDS Research: Its History & Future Meeting)
... hope for additional nucleosides and we'll hear more maybe from Daria Hazuda on EFdA (islatravir), 00:26:30 a wonderful drug that has tremendous potency. I think ...
Apr 27, 2021
... hope for additional nucleosides and we'll hear more maybe from Daria Hazuda on EFdA (islatravir), 00:26:30 a wonderful drug that has tremendous potency. I think ...
Apr 27, 2021
3.5 Daria Hazuda: Discovery and Development of Integrase Inhibitors
(HIV/AIDS Research: Its History & Future Meeting)
... Kayla B. Matzek, Kamlendra Singh, et al. “4′Ethynyl2Fluoro2′Deoxyadenosine (EFdA) Inhibits HIV1 Reverse Transcriptase with Multiple Mechanisms.” Journal of Biological Chemistry 289 ...
Apr 27, 2021
... Kayla B. Matzek, Kamlendra Singh, et al. “4′Ethynyl2Fluoro2′Deoxyadenosine (EFdA) Inhibits HIV1 Reverse Transcriptase with Multiple Mechanisms.” Journal of Biological Chemistry 289 ...
Apr 27, 2021